Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA personnel retention

This article was originally published in The Gray Sheet

Executive Summary

Annual turnover rate of 8% among employees indicates that morale at the agency is improving, FDA Deputy Commissioner Lester Crawford tells AdvaMed attendees. "We believe that traditionally and historically about an 8% turnover of personnel on an annual basis is a helpful thing for FDA," he said, noting, "it would be very difficult to manage any material changes in the personnel profile at FDA if we had no turnover." However, if the agency experienced "20-30% turnover every year, that would also be virtually unmanageable," he pointed out. One way FDA is able to maintain key personnel is through a program that allows the agency to forgive student loans of up to $40,000 for medical officers and give them a signing bonus of up to 25% of their base salary, Crawford explained. In terms of recruiting, the agency is "very competitive in the Washington, [D.C.] area," he opined...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018115

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel